Home
Chemical Prices
Azithromycin

Azithromycin Price Trend and Forecast

Get Real Time Prices

Azithromycin Price Trend and Forecast

Get Real Time Prices

Market Overview

For the Quarter Ending June 2023

North America

The prices of Azithromycin witnessed an upward trend in North America during the second quarter of 2023. An increment of 7.73% is seen in June compared to the levels noted in April due to an increase in demand for Azithromycin from the downstream sector and a rise in imports from China. The Manufacturing Purchasing Managers’ (PMI) Index in the US fell to 46.3 in June from the beginning of the second quarter. This indicates a contraction of production growth, leading to a high supply of Azithromycin coupled with more demand from the pharmaceuticals and nutraceuticals sectors. Apart from this, replenishment of product inventories with fresh stock in the mid of the quarter Q2 2023 has kept the market sentiments north side. Also, the decrease in inflation and energy prices has increased the consumers’ confidence leading to a gradual rise in Azithromycin prices in the second quarter. Imports prices increased in the US, demonstrating more quantity of imports of Azithromycin API from China balanced with more demand from end consumers, keeping the price on the higher side.

Asia Pacific

The price of Azithromycin rose significantly by 9.45 percent in June compared to levels observed in April. The factors responsible for this upward trend include high demand from the downstream sector amid antibiotic resistance bacteria. The CPI (Consumer Price Index) increased in May, indicating a rise in inflation in the mid of Q2 2023 that led to an increase in the prices of raw materials required in making the Azithromycin API. Apart from that, a rise in energy and oil prices has a significant role in the surging of Azithromycin prices in the domestic market as well as in foreign markets due to increased costs for businesses that rely on APIs. PMI (Purchasing Managers’ Index) of China was 49.5 in April, which increased to 50.9 in May, indicating the expansion of China’s industrial activity, along with more demand, led to a rise in the Azithromycin prices. Also, despite the ease of COVID protocols, the supply chain remains disrupted, increasing the overall transportation cost and increasing prices.

Europe

Azithromycin prices in Europe demonstrated an upward trend due to persistent demand from the downstream sector and imports from exporting countries such as China. Inflation in Germany has increased to 6.4 percent in June from May, leading to the high cost of developing and maintaining APIs. Demand for Azithromycin also increased in domestic and foreign markets, which put upward pressure on Azithromycin prices. Also, the war in Ukraine caused high energy prices in Germany that led to a rise in Azithromycin prices as the cost of production of APIs increased. The Manufacturing Purchasing Manager Index (PMI) of Germany fell to 41 in June 2023, contrasted with levels noted at the start of the second quarter. This demonstrates the contraction of production growth coupled with higher demand from the end-user sector, leading to a rise in Azithromycin prices in the market. Also, prices of Azithromycin API remained high in China in the second quarter, which made the API expensive to import in Germany.

For the Quarter Ending March 2023

North America

Azithromycin displayed stable market dynamics throughout the first quarter of 2023. With the start of Q1 2023, prices were recorded to increase stably, supported by sustained purchases from the pharmaceutical end-user industry and merchant stocks to meet demand. Also, the ease of trade disruption supported the Azithromycin market trend. With an average quarterly inclination of 0.40%, the settlement price of Azithromycin API was recorded at USD 103750/MT CFR Houston. Enough inventories among the merchants and the domestic suppliers kept the market situation firm. With stable production costs and ease in demand, trading activities were also feeble, keeping the market Weak.

Asia

Azithromycin prices witnessed a positive trajectory in the APAC region in the first quarter of 2023. At the commencement of Q1 2023, the prices recorded to drop backed by sufficient inventories and a stable demand outlook. Later with the onset of February, After the Lunar New Year break, the Chinese pharmaceutical markets technically returned on a positive note with an increase in orders and shipments from both the domestic and the international market. As the market was reopened, factory and port operations resumed. Also, with the soaring offtake and increase in the no. of international orders, Azithromycin prices increased in the Chinese market. At the termination of Q1 202, the settlement price of Azithromycin API was accessed at USD 101340/MT FOB Shanghai with an average quarterly inclination of 1.33%.

Europe

The first quarter of 2023 saw stable market dynamics for Azithromycin. Prices started to rise steadily at the beginning of Q1 2023, helped by ongoing purchases from the pharmaceutical end-user business and merchant stockpiles to fulfill demand. The settlement price for azithromycin API was recorded at USD 105560/MT CFR Houston, with an average quarterly inclination of 0.54%. The market position remained stable thanks to sufficient stockpiles held by retailers and domestic suppliers. The market remained weak due to stable manufacturing costs, easy demand, and weak trade activity. Also, the reduced energy prices further lower doe the production cost keeping the market weak.

For the Quarter Ending December 2022

North America

The North American market for Azithromycin initiated the Q4 of 2022 on an upward note, with prices settled at USD 103700 per MT in October. However, these prices started plunging slowly in November and fell even further to USD 102500 per MT in December. The Golden week vacation in the first week of October and repeated lockdowns in China, from which most APIs are imported, significantly reduced imports into the US. As a result, domestic retailers had to raise their prices, considering the low inventories in the market. Consequently, improvement in import frequencies from China led to adequate stock in the market, causing the value to be slightly lower. Also, demand from the downstream pharmaceutical sector in the US reduced in November ahead of the Christmas Holiday. All these factors had a prominent effect on the mixed price trend of Azithromycin in the US domestic market.

Asia- Pacific

Azithromycin prices showcased a see-saw trend in the Asia Pacific region throughout the fourth Quarter of 2022. Some industries were shutdowns due to a long week holiday in the first week of October and later stringent lockdowns resulting in increased risks of further uncertainties in production, operations, logistics, and supply chain activities. Considering the situation, Chinese manufacturers raised their prices of Azithromycin to USD 99000/MT in October to maintain stability in their profit margin. In contrast, prices started declining from the onset of November as demand from the downstream pharmaceutical industries was stable to weak amid the slowdown in China's economy. Towards the end of Q4, prices dropped to USD 97400/MT, supported by sufficient regional stockpiles as production activities resumed.

Europe

Prices for Azithromycin remained high in Europe with the onset of the fourth quarter of 2022 due to limited inventories and constantly increased demand from end-user industries such as pharmaceutical and healthcare sectors. Inadequate imports from major exporting countries, mainly China, were seen due to the Golden Week holiday and lockdown restrictions. Also, the conflict between Russia and Ukraine caused disruption in the supply chain and increased freight costs. However, prices began to drop from November to late December due to the poor offtakes and the underwhelming downstream demand. Additionally, the suppliers had an adequate supply on hand to cover the entire domestic demand. As a ripple effect, Azithromycin CFR Hamburg prices declined from USD 105040/MT to USD 103860/MT from October to December 2022.

For the Quarter Ending September 2022

North America

In the third quarter of 2022, the price trend for Azithromycin API in the North American region followed a downward path. The weak demand from the downstream pharmaceutical sector and sufficient stocks among the domestic merchants further affected the prices of Azithromycin API. The Azithromycin API market saw volatility during the third quarter because of the interrupted supply chain from China. Towards the closure of the quarter, Azithromycin API prices were estimated at USD 100800/MT for CFR New York, with a quarterly tendency of 6.6%. Overall, these variables significantly influenced the declining price trend along with the declining demand throughout the quarter.

Asia- Pacific

Entering Q3 2022, the market of Azithromycin API encountered the Asia Pacific market with a downward price trajectory until the first half of September. This decline in China results from weak market sentiments, decreased demand from downstream pharmaceutical industries, and slow offtakes from the domestic market. However, the manufacturers had enough inventory of Azithromycin API in hand to cater to the orders made for immediate use. Moreover, trading activities from China to the international market remained disturbed from July due to numerous factors, such as lockdown restrictions and the shutdown of factories for maintenance, which impacted the Azithromycin API price trend. Therefore, by the end of Q3, slight improvements were seen in Azithromycin demand dynamics, due to which mainstream factories raised the prices from USD 97000/MT to USD 99000/MT FOB Shanghai.

Europe

In Europe, the Azithromycin API witnessed a similar price trend to the Asia-Pacific region during the Q3 of FY2022. However, Azithromycin API prices declined by 3.94% until August, backed by abundant availability and unstable demand from the downstream sectors. Moreover, Europe's already challenging economic situation was made even more difficult by the unrest in Russia and Ukraine and the lockdown and port restrictions in China, a major supplier. With a slight recovery in demand and purchasing activities from end-user pharmaceutical industries in October, the prices of Azithromycin API in Germany were shifted from USD 102850/MT to USD 105040/MT with an inclination of 2.13%.

For the Quarter Ending June 2022

North America

In the second quarter of 2022, the prices of Azithromycin API in the North American region continued to follow a downward trend due to declining demand from the downstream pharmaceutical sector. Adequate inventories in the domestic market have substantially pressurized Azithromycin API's market sentiments to be on the lower side. Additionally, the zero covid policy in China amid the resurgence of COVID cases has abrupted the global supply chain and negatively impacted the price trends of Azithromycin API in the United States. The CFR prices for Azithromycin API were assessed at USD 124500/MT in the United States at the end of the quarter.

Asia- Pacific

The Asia Pacific region has had conflicting market attitudes toward Azithromycin API during the second quarter of 2022. Due to the weak demand and sufficient inventories in the downstream pharmaceutical industries, Azithromycin API prices declined in China in April. Besides, the ongoing Covid shutdown in some cities of China has impacted the market sentiments of Azithromycin API. However, Azithromycin API prices decreased since the middle of the quarter because of a backlog of deliveries piling up, and the manufacturers provoked to reduce their quotations. The pricing of Azithromycin API has also benefited from low purchasing and selling activity across the regional market. Thus, by the quarter ending June, prices of Azithromycin API were assessed at USD 120000/MT in China.

Europe

During the second quarter of 2022, Azithromycin API has witnessed downward trend in Europe. In April, Azithromycin API prices in the European market declined due to continuous importing activities from China amidst lockdown restrictions, causing sufficient inventories in the regional market of Europe. However, Azithromycin API prices declined in May by 5.42%, backed by received quotations from China and ample availability coupled with fragile demand from the downstream sectors. Prices of Azithromycin API in Germany were settled at USD 131300/MT with growing demand and favorable buying sentiments in the downstream pharmaceutical sectors.

How we can help

ChemAnalyst tackles the primary difficulty areas of the worldwide chemical, petroleum, pharmaceutical, and petrochemical industries, empowering decision-makers to make informed decisions. It examines and analyses geopolitical risks, environmental concerns, raw material availability, supply chain functioning, and technological disruption. It focuses on market volatility and guarantees that clients manage obstacles and hazards effectively and efficiently. ChemAnalyst's primary expertise has been data timeliness and accuracy, benefiting both local and global industries by tuning in to real-time data points to execute multibillion-dollar projects internationally.

Services

Market Analysis

Company-wise installed capacity, production volume and plant operating efficiency is captured directly from manufacturers. Import and Export volume is captured from government sources and demand for Azithromycin is calculated considering the production, import, export and inventory-levels on the country and regional level markets.

Learn More

Pricing Analysis

The product price is correlated with the price trend of crude oil, demand-supply gap, fluctuations in the feedstock and with the market movement of the downstream sectors.

Learn More

Company Profile

Basic details and information on financial performance of leading global players in the Azithromycin market is presented in a visually captivating manner. Expansion plans and the company’s strategy is also captured to understand the vision and mission of the company to help understand the areas where companies need to focus more.

News & Deals

Daily updates on industry-specific and product-specific news, exclusive primary-based news capturing plant shutdowns/outages/closures, capacity expansions, operating rates, insights on demand-supply situation, awarding of technology licenses, new product launch and deals specifying mergers and acquisitions, strategic investments and disinvestments, to help players capitalize on market opportunity.

Learn More

Methodology

ChemAnalyst collects information through primary research surveys conducted with various Azithromycin manufacturers from the domestic and international markets, suppliers, and dealers or distributors to gain insights into value chains and the demand-supply scenario to assess the market situation. A thorough examination of the company's annual reports and secondary sources, such as an intensive search of trustworthy paid databases, including our internal database, is performed to validate the facts. All information gathered is reviewed, assessed, and presented in chronological sequence to provide a relevant and clear picture of the market.

Our committed industry specialists meticulously watch and analyze different aspects of the Global Azithromycin market. The team examines numerous industrial segments and strategic perspectives and gives a long-term study of the industry's performance. This would allow our clients to plan their future investments more effectively, manage risk, comprehend cost dynamics, and strike a balance in the face of market volatility.

A critical analysis of the influence of the COVID-19 pandemic on global supply chains, shifts in demand patterns, and changes in consumer purchasing behavior worldwide.

Several active development projects across sectors are monitored, followed by specifics of important initiatives in the development stage that might affect the Global Azithromycin market favorably or adversely.

Pricing is gathered through extensive primary interviews with domestic and foreign producers, traders, importers, and customers daily, weekly, monthly, and yearly.

Finally, Azithromycin market segments are examined, and regional demand patterns are followed.

About

Azithromycin is an active pharmaceutical ingredient having the molecular formula C38H72N2O12. It is present in white powder form. It is applied in various dosage forms of finished products, such as a tablet, injections, and ophthalmics. It has an antibiotic property used to treat several bacterial infections, including middle ear infections, strep throat, and pneumonia. It will resist harmful microorganisms from growing and may fight a large variety of microorganisms, together with several within the eubacteria family. It is also utilized for the preparation of COVID-19 drugs. It is an active ingredient in products such as Azithromycin Dihydrate, monohydrate, and trihydrate. The major global market players include Alembic Pharmaceutical Limited, Pfizer, Teva, Mylan, Hainan Poly Pharm, and Hainan Hailing Chemipharma Corporation.

Product Specific Details

CAS No.	83905-01-5
HS Code	29419090
Grade	USP, IP, Ph. Eur/EP
Approved Facility	CDSCO (FDA India), USFDA
Certifications	GMP, cGMP, CEP

Approved Facility/Certification Definitions:

CDSCO- The Central Drugs Standard Control Organization (CDSCO) - Under the Drugs and Cosmetics Act, CDSCO is responsible for approval of Drugs, Conduct of Clinical Trials, laying down the standards for Drugs, control over the quality of imported Drugs in the country and coordination of the activities of State Drug Control Organizations by providing expert advice.

USFDA - The United States Food and Drug Administration (FDA or US FDA) is a federal agency of the Department of Health and Human Services. FDA is also responsible for advancing the public health by accelerating innovations to make medicines more effective and providing the public with accurate, science-based information on medicines and food to improve their health. FDA plays a significant role in addressing the Nation's counterterrorism capability and ensuring the security of the food supply.

GMP- Good manufacturing practice (GMP) is a system for ensuring that products are consistently produced and controlled according to quality standards.

cGMP- It refers to the Current Good Manufacturing Practice regulations enforced by the FDA. cGMP requires manufactures to employ technologies and systems that are up to date and comply with GMP regulations.

CEP - The Certificate of Suitability or CEP is a certificate issued by the European Directorate for the Quality of Medicines (EDQM) that certifies the compliance of a pharmaceutical substance or active pharmaceutical ingredient (API) with the requirements of the relevant monograph.

Get real-time pricing intelligence for different pharmaceutical products traded worldwide under mentioned Incoterms:

Incoterms: FOB/CFR/CIF/Ex-Works/ Ex-Location

Incoterms Definitions -

CFR - The price at which a country imports a commodity, which includes the cost of the commodity and freight charges.

FOB - The price at which a country is exporting its commodities.

FD (Free Del.) - Price deals are valid for free delivered commodities sold in the sphere of 300 sq. km in NWE (Northwest Europe).

Ex-works - These are the actual factory price which does not include any logistics charges.

Ex-Location - These are the prices of traders/suppliers/distributors for domestic trade purposes.

Taxes - The prices shown on the portal are exclusive of all taxes such as GST or VAT

Discounts - ChemAnalyst does not consider relevant bulk, trade, or contract discounts.

Countries Covered:

• China

• India

• USA

• Germany

Track real-time price movement of 400+ chemical and petrochemical products for informed purchase decisions

Azithromycin Price Trend and Forecast

Our Clients